Dr. Joshi is a Yale-trained, ABPN board-certified geriatric psychiatrist and recipient of the APA Hartford-Jeste Award — the field's most distinguished recognition for contributions to geriatric psychiatry. She brings expertise in the full spectrum of late-life psychiatric presentations: Alzheimer's disease and related dementias, neuropsychiatric symptoms of dementia, late-life depression and anxiety, and the complex interplay of psychiatric illness and cognitive decline. She is an active clinical trialist and first-author of multiple peer-reviewed publications on dementia care.

Older adults are frequently prescribed multiple medications by multiple providers, creating a complex and sometimes harmful drug burden. Dr. Joshi specializes in careful, evidence-based deprescribing — reducing or discontinuing medications whose risks outweigh their benefits, with attention to cognitive, functional, and quality-of-life outcomes.

Substance use disorders in later life are frequently underrecognized and undertreated. Dr. Joshi combines her board certification in addiction medicine with her geriatric psychiatry subspecialty to offer expert evaluation and management — including alcohol use disorder, opioid use disorder, and prescription medication misuse — with particular attention to the unique pharmacology and medical complexity of aging patients.

ADHD is frequently undiagnosed or misdiagnosed in older adults, where symptoms may overlap with cognitive decline, mood disorders, or the effects of polypharmacy. Dr. Joshi offers expert evaluation of ADHD presenting in later life — carefully distinguishing attentional and executive deficits from dementia-related symptoms — and provides individualized treatment with attention to the unique pharmacological considerations of the aging brain.

Hypoactivity in the frontal lobe may lead to deficits in focus, concentration, task salience, and difficulty controlling impulsive or appetitive behaviors. Dr. Rymowicz is an expert in treating ADHD in adults using all available treatment modalities.

Dr. Rymowicz has experience treating withdrawal from the hospital and the home. Outpatient detox treatment, done safely at home, is often possible.

Sedative-hypnotic withdrawal is notoriously difficult. Dr. Rymowicz is an expert in benzodiazepine discontinuation, offering both anticonvulsant-supported rapid tapers and slow, gentle tapers — in accordance with patient preference.

Dr. Rymowicz is an expert in the medication-assisted treatment of substance use disorders, with noted expertise in opioid, stimulant, and alcohol use disorders, offering all available treatments except methadone.

Dr. Rymowicz has extensive experience treating general psychiatric disorders across all treatment settings — from outpatient to acute inpatient to the long-term treatment of the criminally insane. He has experience treating first responders with PTSD.

Where Dr. Rymowicz is unable to provide treatment directly, he is able to use his professional connections to make the best possible referrals.

Dr. Rymowicz is a leading expert in the emerging field of food addiction, having given the first presentations on the topic at the annual meetings of national conferences. As the science progresses and more effective medications become available, we now have highly effective treatments for distressing thoughts about food and for weight loss.